AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

PrEP

NIH-Funded Study Finds Daily Dose of Antiretroviral Drug Reduces Risk of HIV

blog.aids.gov

Today, the New England Journal of Medicine published research findings from the iPrEx study funded by the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation testing the efficacy of pre-exposure prophylaxis (PrEP). The study is a major step forward in our ability to prevent new HIV infections. The study found that…

President Obama Welcomes New HIV Prevention Research Results

blog.aids.gov

WASHINGTON, D.C. – Today, the National Institutes of Health announced findings on recent HIV prevention research.  The study finds that a daily dose of an oral antiretroviral drug taken by HIV-negative gay and bisexual men reduced the risk of acquiring HIV infection by 43.8 percent, and had even higher rates of effectiveness, up to 73…

New Announcement about PrEP from NIH

NIAID

The National Institutes of Health National Institute of Allergy and Infectious Diseases just made a significant announcement on pre-exposure prophylaxis (PrEP). I am proud to share this important update from the NIH with our blog readers. Learn more by reading this Q&A.

Interview with Ernest Hopkins and Bob Grant about Pre-exposure Prophylaxis (PrEP)

blog.aids.gov

Recently I sat down with Ernest Hopkins, Legislative Director at the San Francisco AIDS Foundation , and Bob Grant, M.D.,M.P.H. , Senior Investigator at the Gladstone Institute at University of California San Francisco , to talk about pre-exposure prophylaxis (PrEP). Here is a video from our conversation.

Future Priorities for NIAID’s HIV Prevention Research

Future Directions for NIAID HIV Research

As we begin to discuss the restructuring of NIAID’s clinical trials networks, let us first focus on the Institute’s HIV prevention research agenda. Developing new biomedical tools that can safely and effectively prevent HIV acquisition and transmission is critical to addressing the global HIV/AIDS pandemic. Currently, we are exploring several promising HIV prevention strategies that,…

National HIV Prevention Conference Delivers Call to Action

2009 National HIV Prevention Conference. Promoting Synergy Between Science and Programs

I just returned from the National HIV Prevention Conference in Atlanta where a sense of excitement and renewed enthusiasm for fighting the HIV/AIDS pandemic were buoyed by the new opportunities that the Obama administration brings. Conversely, there was also an underlying current of anxiety about how our country’s economic situation is affecting HIV prevention services….

Testing HIV Drugs as Prevention

Dr. Carl Dieffenbach, PhD

Last year, the U.S. Centers for Disease Control and Prevention (CDC) announced that the number of annual new HIV infections in the United States is actually 40% higher than previously estimated. This means that more than 56,000 Americans are infected with HIV every year despite public education efforts on how to avoid getting infected. Addressing…

Page 3 of 3123